Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure.

Date publication

novembre 2024

Journal

European journal of clinical investigation

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick

Tous les auteurs :
Witoslawska A, Meessen JMTA, Hilvo M, Jylhä A, Zannad F, Cerrato M, Rossignol P, Novelli D, Duarte K, Targher G, Latini R, Girerd N, Laaksonen R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39578928

Résumé

Ceramide and phosphatidylcholine lipids-based risk score (CERT2) has shown a strong prognostic value in predicting cardiovascular (CV) events in patients with ischemic heart disease. This study aimed to investigate the prognostic value of CERT2 risk score in patients with heart failure (HF).

Mots clés

cardiovascular event, ceramides, plasma biomarkers, risk score, sphingolipids

Référence

Eur J Clin Invest. 2024 11 23;:e14359